These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 10516936)

  • 21. Lack of effect of grapefruit juice on the pharmacokinetics and pharmacodynamics of amlodipine.
    Vincent J; Harris SI; Foulds G; Dogolo LC; Willavize S; Friedman HL
    Br J Clin Pharmacol; 2000 Nov; 50(5):455-63. PubMed ID: 11069440
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacokinetics of the controlled-release nisoldipine coat-core tablet formulation.
    Heinig R; Ahr G; Hayauchi Y; Kuhlmann J
    Int J Clin Pharmacol Ther; 1997 Aug; 35(8):341-51. PubMed ID: 9266290
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative steady-state pharmacokinetic evaluation of immediate-release topiramate and USL255, a once-daily extended-release topiramate formulation.
    Bialer M; Shekh-Ahmad T; Braun TL; Halvorsen MB
    Epilepsia; 2013 Aug; 54(8):1444-52. PubMed ID: 23692553
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential pharmacokinetics of diclofenac potassium for oral solution vs immediate-release tablets from a randomized trial: effect of fed and fasting conditions.
    Chen C; Bujanover S; Kareht S; Rapoport AM
    Headache; 2015 Feb; 55(2):265-75. PubMed ID: 25546369
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Criteria to assess in vivo performance of sustained release products: application to diltiazem formulations.
    Bialer M; Sussan S; Abu Salach O; Danenberg HD; Ben-David J; Gibor Y; Laor A
    J Pharm Sci; 1995 Oct; 84(10):1160-3. PubMed ID: 8801328
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Assessment of sex differences in pharmacokinetics and pharmacodynamics of amlodipine in a bioequivalence study.
    Abad-Santos F; Novalbos J; Gálvez-Múgica MA; Gallego-Sandín S; Almeida S; Vallée F; García AG
    Pharmacol Res; 2005 May; 51(5):445-52. PubMed ID: 15749459
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Grapefruit juice-felodipine interaction: reproducibility and characterization with the extended release drug formulation.
    Bailey DG; Arnold JM; Bend JR; Tran LT; Spence JD
    Br J Clin Pharmacol; 1995 Aug; 40(2):135-40. PubMed ID: 8562295
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetics of amlodipine in hypertensive patients undergoing haemodialysis.
    Kungys G; Naujoks H; Wanner C
    Eur J Clin Pharmacol; 2003 Aug; 59(4):291-5. PubMed ID: 12845505
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Felodipine and amlodipine in stable angina pectoris: results of a randomized double-blind crossover trial.
    Koenig W; Höher M
    J Cardiovasc Pharmacol; 1997 Apr; 29(4):520-4. PubMed ID: 9156363
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetics of felodipine extended-release tablets in healthy Taiwanese subjects: a retrospective review.
    Hsiao CL; Wu YC; Hsu KY
    Arzneimittelforschung; 2011; 61(8):444-51. PubMed ID: 21950148
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetic analysis of felodipine-grapefruit juice interaction based on an irreversible enzyme inhibition model.
    Takanaga H; Ohnishi A; Matsuo H; Murakami H; Sata H; Kuroda K; Urae A; Higuchi S; Sawada Y
    Br J Clin Pharmacol; 2000 Jan; 49(1):49-58. PubMed ID: 10606837
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bioequivalence study of an extemporaneously prepared oral solution of amlodipine suitable for use in pediatric patients compared to commercial tablets.
    van der Vossen AC; van der Velde I; van den Meiracker AH; van der Nagel BC; Koch BC; Vulto AG; Hanff LM
    Int J Clin Pharmacol Ther; 2016 Jan; 54(1):65-72. PubMed ID: 26558434
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bioequivalence study of generic amlodipine in healthy Thai male volunteers.
    Rojanasthien N; Teekachunhatean S; Jakob K; Gaupp M; Arnold P; Chaichana N; Martin W
    Int J Clin Pharmacol Ther; 2004 Jun; 42(6):330-5. PubMed ID: 15222726
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influence of grape juice and orange juice on the pharmacokinetics and pharmacodynamics of diltiazem in healthy human male subjects.
    Ahmed T; Sajid M; Singh T; Saini GS; Monif T; Saha N; Pillai KK
    Int J Clin Pharmacol Ther; 2008 Oct; 46(10):511-8. PubMed ID: 18826865
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetics and safety of olmesartan medoxomil in combination with either amlodipine or atenolol compared to respective monotherapies in healthy subjects.
    Bolbrinker J; Huber M; Scholze J; Kreutz R
    Fundam Clin Pharmacol; 2009 Dec; 23(6):767-74. PubMed ID: 19659504
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Limited-sampling strategy models for estimating the area under the plasma concentration-time curve for amlodipine.
    Suarez-Kurtz G; Vicente FL; Ponte CG; Buy VL; Struchiner CJ
    Eur J Clin Pharmacol; 1999 Nov; 55(9):651-7. PubMed ID: 10638394
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Trough/peak ratios of once daily angiotensin converting enzyme inhibitors and calcium antagonists.
    Zannad F; Matzinger A; Larché J
    Am J Hypertens; 1996 Jul; 9(7):633-43. PubMed ID: 8806975
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetics of amlodipine and olmesartan after administration of amlodipine besylate and olmesartan medoxomil in separate dosage forms and as a fixed-dose combination.
    Rohatagi S; Lee J; Shenouda M; Haworth S; Bathala MS; Allison M; Rubets I; Heyrman R; Noveck R; Salazar DE
    J Clin Pharmacol; 2008 Nov; 48(11):1309-22. PubMed ID: 18974285
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetic and antihypertensive profile of amlodipine and felodipine-ER in younger versus older patients with hypertension.
    Leenen FH; Coletta E
    J Cardiovasc Pharmacol; 2010 Dec; 56(6):669-75. PubMed ID: 20881606
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of diltiazem bioavailability from 3 marketed extended-release products for once-daily administration: implications of chronopharmacokinetics and dynamics.
    Eradiri O; Midha KK
    Int J Clin Pharmacol Ther; 1997 Sep; 35(9):369-73. PubMed ID: 9314089
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.